The Design and Application of an Automatic Optical Inspection System for the Advanced Fiber Coupler Assembly Manufacturing Process

Chern-Sheng Lin,Jen Min Tsai,Kai-Sheng Chen,Yun-Long Lay,Nin-Chun Chang 한국정밀공학회 2014 International Journal of Precision Engineering and Vol. No.

In this paper an automatic optical inspection system for the advanced fiber coupler assembly manufacturing process is presented. Coupling efficiency variations were compared with axial displacement. The main standard components of light peak fiber couplerswere used in the experiment to determine the corresponding offset and position of the optimal optical coupling efficiency in order toachieve a positioning effect. This study used the parameters of lens curvature, focal length and light source for validation using opticaldesign software. An infrared CCD camera was used to extract the coupled light spot images. The curve fitting method and couplingsimulation database were used for image processing and to calculate optimal coupling efficiency. Under optimal coupling efficiency,the minimum amount of movement of the translation stages was used to calculate the offset of each axle or the coupling efficiencywhen tilted. Moreover, a coupling efficiency database was established. The optical axle center offset in the alignment was calculatedby comparing the data in the database. Finally, the optical axle center offset or tilt direction was identified through the program toachieve the position of optimal coupling efficiency.

Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk Factors

Min-Yu Lan,Hui-Chen Lin,Tsung-Hui Hu,Shu-Fang Chen,Chien-Hung Chen,Yung-Yee Chang,King-Wah Chiu,Tsu-Kung Lin,Shun-Sheng Chen 대한신경과학회 2023 Journal of Clinical Neurology Vol.19 No.1

Background and Purpose Oral nucleos(t)ide analogs (NAs) are the mainstay treatment for chronic hepatitis B (CHB). Myotoxicity is an important extrahepatic effect related to NA treatment. Telbivudine is the NA for CHB that is frequently associated with muscle-related side effects. The risk factors for telbivudine-induced myopathy (TIM) are not yet clear. Methods This study characterized the clinical, magnetic resonance images (MRI), and pathological features of 12 TIM cases. A group of telbivudine-tolerant (TT) patients with CHB who received regular telbivudine treatment during the same period without the occurrence of myopathy was collected. Demographic and clinical factors were compared between the patients with TIM and the TT controls. Factors independently associated with TIM were identified using logistic regression analysis. Results The patients with TIM (males/females: 7/5, mean age: 57 years) developed myopathy after using telbivudine for a median period of 19.5 months. Muscle histopathology revealed abnormal proliferation, subsarcolemmal or sarcoplasmic accumulations, and ultrastructural defects of mitochondria. When compared with TT cases, patients with TIM had a lower estimated glomerular filtration rate and were more frequently positive for hepatitis B e antigen (HBeAg). Conclusions Mitochondrial abnormalities are characteristic histopathological features, and impaired renal function and HBeAg positivity are risk factors for TIM. Telbivudine-induced mitochondrial dysfunction and immune activation related to mitochondrial damage and HBeAg serostatus changes may underlie TIM. Constant clinical surveillance of myopathy during telbivudine treatment is needed due to the significant latency of its development. Dose adjustment for impaired renal function does not eliminate the risk of TIM occurrence.

Influence of Personal Character on Quality of Life of Patients with Esophageal Cancer in North Henan Province and Influencing Factors

Lin, Jian-Ying,Wang, Ming-Sheng,Dong, Liang-Peng,Xu, Da-Wei,Wang, Ying,Li, Xue-Liang,Li, Xiu-Min Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.11

The aim of this study was to investigate QoL (quality of life) of patients with esophageal cancer in northern Henan province, China, and to accurate evaluate and reflect the relationship between patient characteristics and QoL. In the high risk area of esophageal cancer in the north of Henan province, 735 patients with esophageal cancer were investigated. The Eysenck personality questionnaire (EPQ) and QoL were analyzed by using the questionnaire of general situation, EPQ, QLQ-C30 and QLQ-OES18. The effects of personal character on the QoL of esophageal carcinoma patients were analyzed by SPSS 11.0 software. The QoL of esophageal cancer patients in Northern Henan region was significantly affected by character. The difference between choleric and type of melancholic temperament types was significant (P<0.01), also in OESEAT, OESTA, OESCO and OESSP (P<0.05). Differences in personal character can thus influence the quality of esophageal cancer patient lives.

Effect of anti-PMSG on distribution of estrogen receptor alpha and progesterone receptor in mouse ovary, oviduct and uterus

Lin, Zi Li,Ni, He Min,Liu, Yun Hai,Sheng, Xi Hui,Cui, Xiang Shun,Kim, Nam Hyung,Guo, Yong Cambridge University Press 2015 Zygote Vol.23 No.5

<B>Summary</B><P>It is well established that estrogen and progesterone are critical endogenous hormones that are essential for implantation and pregnancy in females. However, the distribution of estrogen receptor α (ERα) and progesterone receptor (PR) in female reproductive tracts is elusive. Herein, we report that after serial treatments with pregnant mare's serum gonadotrophin (PMSG) with or without anti-PMSG (AP), mice could regulate the distribution of ERα and PR in the murine ovary, oviduct and uterus and the level of estradiol in serum. ERα and PR regulation by PMSG and anti-PMSG was estrous cycle-dependent and critical for promoting the embryo-implantation period. Furthermore, our results suggested that AP-42 h treatment is more effective than the other treatments. In contrast, other treatment groups also affected the distribution of ERα and PR in mouse reproductive tracts. Thus, we found that anti-PMSG has the potential to restore the distribution of ERα and PR, which could effectively reduce the negative impact of residual estrogen caused by the normal superovulation effect of PMSG in mice.</P>

Frequent Mutations of p53 and MTS1/CDK4I Tumor Suppressor Genes in Chinese Preneoplastic and Neoplastic Oral Tissues

Li, Sheng-Lin,Baek, Jeong-Hwa,Zhang, Kui-Hua,Min, Byung-Moo,Gujuluva, Chandrasekhar N.,Bertolami, Charles N.,Park, No-Hee Korean Academy of Oral Biology and the UCLA Dental 1996 International Journal of Oral Biology Vol.21 No.1

Aberrant expression and mutation in the p53 and MTS1/CDK41 genes were determined from 11 normal, 8 preneoplastic and 25 neoplastic oral tissues obtained from Beijing, China, using immunostaining, single strand conformational polymorphism analysis, and nucleotide sequencing. Normal tissue showed a negligible amount of p53 immunostaining, while 3 (38%) of 8 preneoplastic, and 16 (64%) of 25 cancer tissues demonstrated moderate to strong p53 immunostaining. Point mutations within exons 5 to 8 were not detected in normal tissue specimens, but were detected in 2 (25%) preneoplastic tissues and in 15 (60%) cancer specimens. OF the tissues with mutations, 2 (100%) preneoplatic and 14 (93%) cancer tissues contained a CGT to CAT mutation at codon 273 of p53 gene. One cancer tissue showed a silent mutation (CGC to CTC) at codon 283. Three cancer specimens containing a point mutation at codon 273 also showed additional silent mutations at codons 156, 157, or 275. These data indicate that p53 mutation is highly prevalent in tested preneoplastic and neoplastic oral tissues and that the codon 273 is the "hot-spot" for point mutations. The enhanced p53 immunostaining was, in general, closely associated with point mutations, but 1 (13%) preneoplastic sample and 5 (20%) neoplastic oral tissues not containing point mutations within exons 5 to 8 demonstrated enhanced immunostaining. Over 62% of preneoplastic and 80% of neoplastic oral tissues contained mutations in MTS1/CDK4I gene, but, unlike p53 mutations, the mutation pattern of MTS1/CDK4I gene was not specific. Two preneoplastic (25%) and 12 neoplastic (48%) tissues contained mutations in both p53 and MTS1/CDK4I genes, and 2 preneoplastic (25%) and 3 neoplastic (12%) tissues contained mutations neither in p53 nor in MTS1/CDK4I genes.

Magnetism and Thermodynamic Properties of a Spin-1/2 Ferrimagnetic Diamond XY Chain in Magnetic Fields at Finite Temperatures

Tai-Min Cheng,Yan-Ming Ma,Chong-Yuan Ge,Shu-Sheng Sun,Wei-Ye Jia,Qing-Yun Li,Xiao-Fei Shi,Lin Li,Lin Zhu 한국물리학회 2013 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.62 No.1

The elementary excitation spectra of a one-dimensional ferrimagnetic diamond chain in the spin- 1/2 XY model at low temperatures have been calculated by using an invariant eigen-operator (IEO) method, the energies of elementary excitations in different specific cases are discussed, and the analytic solutions of three critical magnetic field intensities (<i>H</i>_C1, <i>H</i>_C2, and <i>H</i>_peak) are given. The magnetization versus external magnetic field curve displays a 1/3 magnetization plateau at low temperatures, in which <i>H</i>_C1 is the critical magnetic field intensity from the disappearance of the 1/3 magnetization plateau to spin-flop states, <i>H</i>_C2 is the critical magnetic field intensity from spin-flop states to the saturation magnetization, and Hpeak is the critical magnetic field intensity when the temperature magnetization shows a peak in the external magnetic field. The temperature dependences of the magnetic susceptibility and the specific heat show a double peak structure. The entropy and the magnetic susceptibility versus external magnetic field curves also exhibit a double peak structure, and the positions of the two peaks correspond to <i>H</i>_C1 and <i>H</i>_C2, respectively. This derives from the competition among different types of energies: the temperature-dependent thermal disorder energy, the potential energy of the spin magnetic moment, the ferromagnetic exchange interaction energy, and the anti-ferromagnetic exchange interaction energy. However at low temperatures, the specific heat as a function of external magnetic field curve exhibits minima at the above two critical points (<i>H</i>_C1 and <i>H</i><sub>C2<sub>). The origins of the above phenomena are discussed in detail.

Deformable Liposomes for Topical Skin Delivery of Arbutin

Bian, Sheng-Jie,Choi, Min-Koo,Lin, Hong-Xia,Chung, Suk-Jae,Shim, Chang-Koo,Kim, Dae-Duk,Zheng, Jun-Min 한국약제학회 2006 Journal of Pharmaceutical Investigation Vol.36 No.5

Low Expression of Tyrosine-protein Phosphatase Nonreceptor Type 12 is Associated with Lymph Node Metastasis and Poor Prognosis in Operable Triple-negative Breast Cancer

Wu, Min-Qing,Hu, Pan,Gao, Jie,Wei, Wei-Dong,Xiao, Xiang-Sheng,Tang, Hai-Lin,Li, Xing,Ge, Qi-Dong,Jia, Wei-Hua,Liu, Ren-Bin,Xie, Xiao-Ming Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.1

Background: Low tyrosine-protein phosphatase nonreceptor type 12 (PTPN12) expression may be associated with breast cancer growth, proliferation, and metastasis. However, the prognostic value of PTPN12 in breast cancer has not been clearly identified. Patients and Methods: 51 triple-negative breast cancer (TNBC) patients and 83 non-TNBC patients with a histopathology diagnosis from October 2001 to September 2006 were included in this study. Immunohistochemical staining for PTPN12 on tissue microarrays was conducted. Results: High PTPN12 expression was seen in 39.2% of TNBC and 60.2 % of non-TNBC cases. Low PTPN12 expression was associated with lymph node status (p = 0.002) and distant metastatic relapse (p = 0.002) in TNBC patients. Similarly, low PTPN12 expression in non-TNBC patients was significantly correlated with lymph node status (p = 0.002), stage (p = 0.002) and distant metastatic relapse (p = 0.039). The high PTPN12 expression group was associated with longer DFS and OS compared with low PTPN12 expression group only in TNBC cases (p = 0.005, p = 0.015), according to univariate Cox regression analysis. Conclusion: These findings provide evidence that low expression of PTPN12 is associated with worse prognosis and may be used as a potential prognostic biomarker in TNBC patients.

Mutational Analysis of Key EGFR Pathway Genes in Chinese Breast Cancer Patients

Tong, Lin,Yang, Xue-Xi,Liu, Min-Feng,Yao, Guang-Yu,Dong, Jian-Yu,Ye, Chang-Sheng,Li, Ming Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.11

Background: The epidermal growth factor receptor (EGFR) is a potential therapeutic target for breast cancer treatment; however, its use does not lead to a marked clinical response. Studies of non-small cell lung cancer and colorectal cancer showed that mutations of genes in the PIK3CA/AKT and RAS/RAF/MEK pathways, two major signalling cascades downstream of EGFR, might predict resistance to EGFR-targeted agents. Therefore, we examined the frequencies of mutations in these key EGFR pathway genes in Chinese breast cancer patients. Methods: We used a high-throughput mass-spectrometric based cancer gene mutation profiling platform to detect 22 mutations of the PIK3CA, AKT1, BRAF, EGFR, HRAS, and KRAS genes in 120 Chinese women with breast cancer. Results: Thirteen mutations were detected in 12 (10%) of the samples, all of which were invasive ductal carcinomas (two stage I, six stage II, three stage III, and one stage IV). These included one mutation (0.83%) in the EGFR gene (rs121913445-rs121913432), three (2.50%) in the KRAS gene (rs121913530, rs112445441), and nine (7.50%) in the PIK3CA gene (rs121913273, rs104886003, and rs121913279). No mutations were found in the AKT1, BRAF, and HRAS genes. Six (27.27%) of the 22 genotyping assays called mutations in at least one sample and three (50%) of the six assays queried were found to be mutated more than once. Conclusions: Mutations in the EGFR pathway occurred in a small fraction of Chinese breast cancers. However, therapeutics targeting these potential predictive markers should be investigated in depth, especially in Oriental populations.

Metastatic Axillary Lymph Node Ratio (LNR) is Prognostically Superior to pN Staging in Patients with Breast Cancer -- Results for 804 Chinese Patients from a Single Institution

Xiao, Xiang-Sheng,Tang, Hai-Lin,Xie, Xin-Hua,Li, Lai-Sheng,Kong, Ya-Nan,Wu, Min-Qing,Yang, Lu,Gao, Jie,Wei, Wei-Dong,Xie, Xiaoming Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.9

The number of axillary lymph nodes involved and retrieved are important prognostic factors in breast cancer. The purpose of our study was to investigate whether the lymph node ratio (LNR) is a better prognostic factor in predicting disease-free survival (DFS) for breast cancer patients as compared with pN staging. The analysis was based on 804 breast cancer patients who had underwent axillary lymph node dissection between 1999 and 2008 in Sun Yat-Sen University Cancer Center. Optimal cutoff points of LNR were calculated using X-tile software and validated by bootstrapping. Patients were then divided into three groups (low-, intermediate-, and high-risk) according to the cutoff points. Predicting risk factors for relapse were performed according to Cox proportional hazards analysis. DFS was estimated using the Kaplan-Meier method and compared by the log-rank test. The 5-year DFS rate decreased significantly with increasing LNRs and pN. Univariate analysis found that the pT, pN, LNR, molecule type, HER2, pTNM stage and radiotherapy well classified patients with significantly different prognosis. By multivariate analysis, only LNR classification was retained as an independent prognostic factor. Furthermore, there was a significant prognostic difference among different LNR categories for pN2 category, but no apparent prognostic difference was seen between different pN categories in any LNR category. Therefore, LNR rather than pN staging is preferable in predicting DFS in node positive breast cancer patients, and routine clinical decision-making should take the LNR into consideration.